2024 -- S 2704 SUBSTITUTE A | |
======== | |
LC005006/SUB A | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2024 | |
____________ | |
A N A C T | |
RELATING TO FOOD AND DRUGS -- KRATOM CONSUMER PROTECTION ACT | |
| |
Introduced By: Senators Gallo, Cano, Sosnowski, and Bissaillon | |
Date Introduced: March 01, 2024 | |
Referred To: Senate Health & Human Services | |
It is enacted by the General Assembly as follows: | |
1 | SECTION 1. Title 21 of the General Laws entitled "FOOD AND DRUGS" is hereby |
2 | amended by adding thereto the following chapter: |
3 | CHAPTER 28.12 |
4 | KRATOM CONSUMER PROTECTION ACT |
5 | 21-28.12-1. Short title. |
6 | This chapter shall be known and may be cited as the "Kratom Consumer Protection Act." |
7 | 21-28.12-2. Definitions. |
8 | As used in this chapter: |
9 | (1) "Civil division" means the unit under the civil division of the Rhode Island attorney |
10 | general’s office. |
11 | (2) "Food" means a dietary ingredient, dietary supplement, botanical supplement, or |
12 | beverage for human consumption. |
13 | (3) "Kratom extract" means a dietary ingredient, dietary supplement, or botanical |
14 | supplement containing any part of the leaf of the plant Mitragyna speciosa that has been extracted |
15 | and concentrated in order to provide more standardized dosing. |
16 | (4) "Kratom product" means a dietary ingredient, dietary supplement, or botanical |
17 | supplement, containing any part of the leaf of the plant Mitragyna speciosa or an extract of it; is |
18 | manufactured as a powder, capsule, pill, beverage, or other edible form; and all kratom products |
19 | are dietary ingredients, dietary supplements, or botanical supplements. |
| |
1 | (5) "Processor" means a person that sells, prepares, manufactures, distributes, or maintains |
2 | kratom products. |
3 | (6) "Retailer" means any person that sells, distributes, advertises, represents, or holds itself |
4 | out as selling or maintaining kratom products. |
5 | (7) "Court” means the superior court. |
6 | (8) "Underage individual" or "underage individuals" means any individual under the age |
7 | of twenty-one (21) years. |
8 | 21-28.12-3. Kratom product limitations. |
9 | A processor shall not prepare, distribute, sell, or advertise any of the following: |
10 | (1) A kratom product that is labeled as a food and deemed adulterated. A kratom product |
11 | that is labeled as a food shall be deemed adulterated if it bears or contains any poisonous or |
12 | deleterious substance which may render it injurious to health. If the substance is not an added |
13 | substance such food shall not be considered adulterated if the quantity of the substance in such food |
14 | does not ordinarily render it injurious to health. |
15 | (2) A kratom product that is labeled as a dietary supplement and deemed adulterated. A |
16 | kratom product that is labeled as a dietary supplement shall be deemed adulterated if it contains a |
17 | dietary ingredient that presents a significant or unreasonable risk of illness or injury under |
18 | conditions of use recommended or suggested in labeling, or if no conditions of use are suggested |
19 | or recommended in the labeling, under ordinary conditions of use. |
20 | (3) A kratom product that is contaminated with a dangerous non-kratom substance. A |
21 | kratom product is contaminated with a dangerous non-kratom substance if the kratom product |
22 | contains a poisonous or otherwise deleterious non-kratom ingredient including, but not limited to, |
23 | the substances listed in § 21-28-2.08. |
24 | (4) A kratom extract that contains levels of residual solvents higher than is allowed in the |
25 | U.S. Pharmacopeia 467. |
26 | (5) A kratom product containing any synthetic alkaloids including synthetic mitragynine, |
27 | synthetic 7-hydroxymitragynine, or any other synthetically derived compounds of the kratom plant. |
28 | (6) A kratom product in any form that is combustible or intended to be used for |
29 | vaporization. |
30 | (7) A kratom product in any form that mimics a candy product or is manufactured, |
31 | packaged, or advertised in a way that appeals to underage individuals. |
32 | (8) A kratom product that does not provide adequate labeling directions necessary for safe |
33 | and effective use by consumers, including: |
34 | (i) A recommendation to consult a health care professional prior to use; |
| LC005006/SUB A - Page 2 of 5 |
1 | (ii) A statement that kratom may be habit forming; |
2 | (iii) A recommendation against the use by individuals who are pregnant or who are |
3 | breastfeeding; |
4 | (iv) The following statement: “These statements have not been evaluated by the United |
5 | States Food and Drug Administration. This product is not intended to diagnose, treat, cure, or |
6 | prevent any disease.”; |
7 | (v) The name and place of business of the processor, manufacturer, packer or distributor; |
8 | (vi) The net quantity of contents declared in numerical count (e.g., 30 capsules), or in |
9 | volume or weight in United States Customary System terms; |
10 | (vii) Directions for use that include all of the following: |
11 | (A) A recommended amount of the kratom product per serving; and |
12 | (B) A recommended number of servings that can be safely consumed in a twenty-four (24) |
13 | hour period. |
14 | 21-28.12-4. Product Registration. |
15 | (a) A processor shall annually register each kratom product it manufactures, packs, |
16 | distributes or labels with the civil division. A product that contains the same kratom ingredients in |
17 | the same kratom delivery form, but a different container, package or volume, shall be included in |
18 | a single registration. |
19 | (b) Annual registration of a kratom product shall include a certificate of analysis from an |
20 | independent laboratory. The laboratory shall be accredited under the standards of the International |
21 | Organization for Standardization 17025:2017 accreditation from an accreditation body that is a |
22 | signatory to the International Laboratory Accreditation Cooperation Mutual Recognition |
23 | Arrangement. |
24 | (c) The certificate of analysis shall include information on each of the kratom product |
25 | components as described in this chapter. |
26 | (d) The processor registering each kratom product shall submit a sworn declaration to the |
27 | civil division that the kratom product meets the requirements for registration and that no dangerous |
28 | substances have been added to the kratom product being registered. |
29 | (e) The civil division may require an independent third-party test of a registered kratom |
30 | product by a laboratory of the civil division’s choice, and the processor shall be required to submit |
31 | payment for the test. If the processor does not tender payment to the civil division within thirty (30) |
32 | days of receipt of the invoice, the civil division unit shall revoke the registration for that product. |
33 | (f) Failure to submit a certificate of analysis shall be cause for denial of product registration. |
34 | (g) A retailer shall pay an annual registration fee set by the civil division prior to selling, |
| LC005006/SUB A - Page 3 of 5 |
1 | distributing or advertising kratom products. |
2 | (h) The civil division is authorized to establish an annual fee for a processor and a retailer |
3 | to cover the administrative costs for processing and administering registrations. |
4 | 21-28.12-5. Age limits. |
5 | A processor shall not distribute, sell, or advertise a kratom product to any underage |
6 | individual. |
7 | 21-28.12-6. Violations. |
8 | (1) A processor or retailer that negligently violates the provisions of this chapter shall be |
9 | subject to a fine of not more than five hundred dollars ($500) for the first offense and not more than |
10 | one thousand dollars ($1,000) for a second or subsequent offense. Upon the request of a person to |
11 | whom a fine is issued, the civil division shall conduct a hearing in accordance with the procedures |
12 | as set forth in chapter 35 of title 42 ("administrative procedures"). |
13 | (2) Upon a third violation, the registration of the retailer shall be revoked, and the retailer |
14 | shall be prohibited from selling any kratom product. |
15 | (3) A retailer is not in violation of the provisions of this chapter if it is shown that the |
16 | retailer relied in good faith upon the representations of a manufacturer, processor, packer or |
17 | distributor of food represented to be a kratom product. |
18 | (4) A person who intentionally, willfully or wantonly violates the provisions of this chapter |
19 | shall be punished by a fine of up to one thousand dollars ($1,000) for the first offense, up to two |
20 | thousand dollars ($2,000) for a second offense, and up to five thousand dollars ($5,000) for a third |
21 | or subsequent offense. |
22 | (5) A person who intentionally, willfully or wantonly violates the provisions of this chapter |
23 | by adulterating a kratom product with any substance listed in § 21-28-2.08 shall be subject to |
24 | penalties set forth in this chapter as well as in § 21-28-4.01. |
25 | 21-28.12-7. Taxation of kratom products. |
26 | A “kratom product” is subject to sales and use tax, at the rates provided in §§ 44-18-18 and |
27 | 44-18-20. |
28 | 21-28.12-8. Removal of mitragynine and 7-hydroxymitragynine from notice of |
29 | designation of controlled substances under schedule I. |
30 | Upon enactment, mitragynine and 7-hydroxymitragynine shall be removed from § 21-28- |
31 | 2.08(g) of the Rhode Island uniform controlled substances act. |
32 | SECTION 2. Section 21-28-2.03 of the General Laws in Chapter 21-28 entitled "Uniform |
33 | Controlled Substances Act" is hereby amended to read as follows: |
34 | 21-28-2.03. Schedule I tests. |
| LC005006/SUB A - Page 4 of 5 |
1 | (a) The director of health shall place a substance in schedule I if he or she finds that the |
2 | substance: |
3 | (1) Has high potential for abuse; and |
4 | (2) Has no accepted medical use in treatment in the United States or lacks accepted safety |
5 | for use in treatment under medical supervision. |
6 | (b) Notwithstanding the provisions of subsection (a) of this section, the director shall have |
7 | no authority to place or maintain mitragynine and 7-hydroxymitragynine in schedule I. |
8 | (c) Federal regulations. If the federal government or any department or agency thereof |
9 | including, but not limited to, the federal Drug Enforcement Agency or Food and Drug |
10 | Administration, issues any rules or regulations with respect to kratom, kratom extracts, kratom |
11 | products, any other derivative of the plant mitragyna speciosa, kratom processors, or kratom |
12 | retailers, such federal rules or regulations shall preempt any provision of this chapter. |
13 | SECTION 3. This act shall take effect on January 1, 2025. |
======== | |
LC005006/SUB A | |
======== | |
| LC005006/SUB A - Page 5 of 5 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO FOOD AND DRUGS -- KRATOM CONSUMER PROTECTION ACT | |
*** | |
1 | This act would authorize and regulate the distribution of the product known as "kratom," |
2 | and would ban the adulteration of kratom with a dangerous non-kratom substance as to render the |
3 | product injurious to a consumer. The act would require that any kratom product contain adequate |
4 | labeling directions necessary for safe and effective use by consumers. |
5 | This act would take effect on January 1, 2025. |
======== | |
LC005006/SUB A | |
======== | |
| LC005006/SUB A - Page 6 of 5 |